Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging-Reference-Cited by-同舟云学术

Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging

Published:2014-11-13 Issue:2 Volume:42 Page:288-301
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Goldstein Robert,Sosabowski Jane,Livanos Maria,Leyton Julius,Vigor Kim,Bhavsar Gaurav,Nagy-Davidescu Gabriela,Rashid Mohammed,Miranda Enrique,Yeung Jenny,Tolner Berend,Plückthun Andreas,Mather Stephen,Meyer Tim,Chester Kerry

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00259-014-2940-2/fulltext.html

Reference41 articles.

1. Arteaga CL, Sliwkowski MX, Osborne CK, Perez EA, Puglisi F, Gianni L. Treatment of HER2-positive breast cancer: current status and future perspectives. Nat Rev Clin Oncol. 2012;9:16–32. doi: 10.1038/nrclinonc.2011.177 .

2. Ross JS. Breast cancer biomarkers and HER2 testing after 10 years of anti-HER2 therapy. Drug News Perspect. 2009;22:93–106. doi: 10.1358/dnp.2009.22.2.1334452 .

3. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687–97. doi: 10.1016/S0140-6736(10)61121-X .

4. Verma S, Miles D, Gianni L, Krop IE, Welslau M, Baselga J, et al. Trastuzumab emtansine for HER2-positive advanced breast cancer. N Engl J Med. 2012;367:1783–91. doi: 10.1056/NEJMoa1209124 .

5. Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31:3997–4013. doi: 10.1200/JCO.2013.50.9984 .

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redesigning amino/carboxyl ends of DARPin G3 for high thermostability and production in tobacco transplastomic plants;Plant Cell Reports;2024-08-10

2. Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion;International Journal of Molecular Sciences;2024-04-11

3. Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the ^99mTc-Based Imaging of HER2-Expressing Malignant Tumors;Molecular Pharmaceutics;2024-04-01

4. A new trivalent recombinant protein for type 2 diabetes mellitus with oral delivery potential: design, expression, and experimental validation;Journal of Biomolecular Structure and Dynamics;2024-03-11

5. Designing and computational analyzing of chimeric long-lasting GLP-1 receptor agonists for type 2 diabetes;Scientific Reports;2023-10-18